Implicity offers a universal remote cardiac monitoring platform that utilizes AI-driven algorithms, including the FDA-cleared SignalHF, to enhance patient monitoring and reduce false positives in ECG analysis. The platform addresses inefficiencies in cardiac care by increasing staff productivity by up to 84% and improving patient reconnection rates by 28%.
Funding
$28.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
EAFounders
Product
Problem
Remote cardiac monitoring often generates a high volume of alerts, many of which are false positives, leading to clinician fatigue and potentially delaying necessary interventions. Existing systems may also struggle with patient connectivity, resulting in incomplete data and hindering effective monitoring.
Solution
Implicity offers an AI-powered remote cardiac monitoring platform designed to improve the efficiency and accuracy of cardiac care. The platform utilizes the FDA-cleared SignalHF algorithm to predict heart failure hospitalizations and reduce false positive alerts from implanted loop recorders (ILRs) by analyzing ECG recordings. By automating patient reconnection and streamlining in-clinic data workflows, Implicity aims to increase staff productivity and improve patient outcomes. The system provides a universal, alert-based platform for remote monitoring of cardiac implantable electronic devices (CIEDs) and supports advanced research through its comprehensive data analysis tools.
Target Audience
The primary target audience includes cardiologists, electrophysiologists, and medical researchers focused on remote cardiac monitoring, as well as hospitals and clinics seeking to improve staff productivity and patient outcomes in heart failure management.
Features
- SignalHF: An FDA-cleared AI algorithm that predicts heart failure hospitalizations using data from CIEDs.
- ILR ECG Analyzer: AI-driven analysis of ECG recordings from Medtronic ILRs, reducing false positives by up to 79% while maintaining 99% sensitivity.
- Patient Connectivity Management: Automated SMS reconnection feature that reconnects 28% of patients who disconnect from remote monitoring.
- AF Alert Management: Reduces unnecessary atrial fibrillation (AF) alerts by 85% compared to alerts transmitted directly by CIEDs.
- Dynamic Billing Engine: Optimizes scheduling and auto-generates reports to achieve over 90% billing compliance.
- InLink: Streamlines in-clinic data workflow for improved efficiency.
- Compatibility with multiple CIED brands (Biotronik, Boston Scientific, and Medtronic).